Gastroenterology
Volume 138, Issue 1 , Pages 305-314 , January 2010

Hepatitis C Virus Core Protein Subverts the Antiviral Activities of Human Kupffer Cells

  • Zhengkun Tu

      Affiliations

    • Department of Surgery, Division of Solid Organ Transplantation and Hepatobiliary Surgery, University of Rochester Medical Center, Rochester, New York
    • ,
  • Robert H. Pierce

      Affiliations

    • Department of Pathology, Schering-Plough Biopharma, Palo Alto, California
    • ,
  • Jonathan Kurtis

      Affiliations

    • Center for International Health Research, Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island
    • ,
  • Yoshio Kuroki

      Affiliations

    • Department of Biochemistry, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • I. Nicholas Crispe

      Affiliations

    • Seattle Biomedical Research Institute, Seattle, Washington
    • ,
  • Mark S. Orloff

      Affiliations

    • Department of Surgery, Division of Solid Organ Transplantation and Hepatobiliary Surgery, University of Rochester Medical Center, Rochester, New York
    • Corresponding Author InformationReprint requests Address requests for reprints to: Mark S. Orloff, MD, University of Rochester Medical Center, Solid Organ Transplantation and Hepatobiliary Surgery, 601 Elmwood Avenue, Rochester, New York 14642. fax: (585) 276-0054

Received 3 October 2008 ,Accepted 11 September 2009.

References 

  1. Trepo C, Zoulim F, Pradat P. Viral hepatitis. Curr Opin Infect Dis. 1999;12:481–490
  2. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol. 2006;1:23–61
  3. Szabo G, Dolganiuc A. Hepatitis C and innate immunity: recent advances. Clin Liver Dis. 2008;12:675–692
  4. Dolganiuc A, Oak S, Kodys K, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004;127:1513–1524
  5. Waggoner SN, Cruise MW, Kassel R, et al. gC1q receptor ligation selectively downregulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol. 2005;175:4706–4714
  6. Lin W, Kim SS, Yeung E, et al. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol. 2006;80:9226–9235
  7. Zimmermann M, Flechsig S, La Monica N, et al. Hepatitis C virus core protein impairs in vitro priming of specific T-cell responses by dendritic cells and hepatocytes. J Hepatol. 2008;48:51–60
  8. Tu Z, Boaogzadeh A, Crispe IN, et al. The activation state of human intrahepatic lymphocytes. Clin Exp Immunol. 2007;149:186–193
  9. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147–163
  10. Sagnelli E, Pasquale G, Coppola N, et al. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis. J Med Virol. 2005;75:222–226
  11. Dolganiuc A, Norkina O, Kodys K, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology. 2007;133:1627–1636
  12. Tu Z, Bozogzadeh A, Pierce RH, et al. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med. 2008;205:233–244
  13. Radziewicz H, Ibegbu CC, Fernandez ML, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol. 2007;81:2545–2553
  14. Iwaki D, Mitsuzawa H, Murakami S, et al. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J Biol Chem. 2002;277:24315–24320
  15. Sharpe AH, Wherry EJ, Ahmed R, et al. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239–245
  16. Golden-Mason L, Palmer B, Klarquist J, et al. Up-regulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol. 2007;81:9249–9258
  17. Lan L, Gorke S, Rau SJ, et al. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol. 2008;181:4926–4935
  18. Kirshner JR, Karpova AY, Kops M, et al. Identification of TRAIL as an interferon regulatory factor 3 transcriptional target. J Virol. 2005;79:9320–9324
  19. Sarkar SN, Peters KL, Elco CP, et al. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol. 2004;11:1060–1067
  20. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003;24:358–363
  21. Hiscott J, Pitha P, Genin P, et al. Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res. 1999;19:1–13
  22. Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol. 2007;13:2406–2415
  23. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest. 2000;106:1239–1249
  24. Cummings KL, Rosen HR, Hahn YS. Frequency of gC1qR(+)CD4(+) T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin Immunol. 2009;132:401–411
  25. Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCVspecific CD8 T-cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathol. 2009;5:e1000313
  26. Nakamoto N, Kaplan DE, Coleclough J, et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology. 2008;134:1927–1937
  27. Cho HY, Lee SWW, Seo SK, et al. Interferon-sensitive response element (ISRE) is mainly responsible for IFN-α-induced up-regulation of programmed death-1 (PD-1) in macrophages. Biochim Biophys Acta. 2008;1779:811–819
  28. Muhlbauer M, Fleck M, Schutz C, et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T-cell apoptosis. J Hepatol. 2006;45:520–528
  29. Schreiner B, Mitsdoerffer M, Kieseier BC, et al. Interferon-α enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol. 2004;155:172–182
  30. Meier A, Bagchi A, Sidhu HK, et al. Up-regulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. Aids. 2008;22:655–658
  31. Jiang Z, Zamanian-Daryoush M. Poly(I-C)-induced toll-like receptor 3 (TLR3)-mediated activation of NF-κB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J Biol Chem. 2003;278:16713–16719
  32. Jiang Z, Mak TW, Sen G, et al. Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at toll-IL-1 receptor domain-containing adapter inducing IFN-α. Proc Natl Acad Sci U S A. 2004;101:3533–3538
  33. Shin OS, Miller LS, Modlin RL, et al. Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K. J Immunol. 2009;183:491–498
  34. Brincks EL, Katewa A, Kucaba TA, et al. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol. 2008;181:4918–4925
  35. Sato K, Hida S, Takayanagi H, et al. Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β. Eur J Immunol. 2001;31:3138–3146
  36. Sen GC, Sarkar SN. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev. 2005;16:1–14
  37. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem. 2007;282:15325–15329
  38. Burgio VL, Ballardini G, Artini M, et al. Expression of costimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology. 1998;27:1600–1606
  39. Wertheimer AM, Polyak SJ, Leistikow R, et al. Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells. Hepatology. 2007;45:1422–1432
  40. Ebihara T, Shingai M, Matsumoto M, et al. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology. 2008;48:48–58
  41. Vanhaesebroeck B, Ali K, Bilancio A, et al. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci. 2005;30:194–204
  42. Seki E, De Minicis S, Osterreicher OH, et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med. 2007;13:1324–1332

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported in part by the Transplant Miracles Foundation.

PII: S0016-5085(09)01648-5

doi: 10.1053/j.gastro.2009.09.009

Gastroenterology
Volume 138, Issue 1 , Pages 305-314 , January 2010

Article Tools

* Image Usage & Resolution